News und Analysen
![SoFi stock to have huge earnings growth, markets like the story: https://www.marketbeat.com/logos/articles/med_20240128175136_sofi-stock-to-have-huge-earnings-growth-markets-li.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXNhYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2559f9709d1824d146e8755d3d1ab40af9369d0e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240128175136_sofi-stock-to-have-huge-earnings-growth-markets-li.jpg?locale=de)
SoFi stock to have huge earnings growth, markets like the story
Many market participants have become weary of the new all-time highs being pushed out by the market indices, such as the broader S&P 500 or the technology-heavy NASDAQ. The law of the market stood
![Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73395/AC-290124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOG9aYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--111128a1a088ae5554406cf81bdf217f8ba0a99a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-290124.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. 192% Biotech Hot Stock nach 134.452% mit Biogen
29.01.24 08:02
London (www.aktiencheck.de , Anzeige)
![Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73395/AC-290124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOG9aYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--111128a1a088ae5554406cf81bdf217f8ba0a99a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-290124.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. 192% Biotech Hot Stock nach 134.452% mit Biogen
29.01.24 08:02
London (www.aktiencheck.de , Anzeige)
![Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73395/AC-290124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOG9aYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--111128a1a088ae5554406cf81bdf217f8ba0a99a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-290124.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Hautkrebs vollständig geheilt. 192% Biotech Hot Stock nach 134.452% mit Biogen
29.01.24 08:02
London (www.aktiencheck.de , Anzeige)
![Snowflake breaks resistance hinting at momentum shift: https://www.marketbeat.com/logos/articles/med_20240126100519_snowflake-breaks-resistance-hinting-at-momentum-sh.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFFZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e23829409668d2185b9af99b56b1ef9d225b7ae0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126100519_snowflake-breaks-resistance-hinting-at-momentum-sh.jpg?locale=de)
Snowflake breaks resistance hinting at momentum shift
Shares of Snowflake Inc. (NYSE: SNOW), a cloud-based data storage, computing, and analytics company, have been impressive lately, with its stock rising almost 50% over the previous three months.
![What makes Textron a must-own aerospace stock for 2024?: https://www.marketbeat.com/logos/articles/med_20240126092917_what-makes-textron-a-must-own-aerospace-stock-for.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3dZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bea23c682db370ec2cb28e62d9b56dbfd7cdb724/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126092917_what-makes-textron-a-must-own-aerospace-stock-for.jpg?locale=de)
What makes Textron a must-own aerospace stock for 2024?
A 9% jump during Wednesday's session made Textron Inc. (NYSE: TXT) one of the best-performing equities on the market. This latest jump in share price for the Rhode Island-based aerospace company
![Is Nike consolidating before a fresh rally?: https://www.marketbeat.com/logos/articles/med_20240126092539_is-nike-consolidating-before-a-fresh-rally.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3NZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a973e1215e5f04bd4e1b18308279c7b5184e9ecf/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126092539_is-nike-consolidating-before-a-fresh-rally.jpg?locale=de)
Is Nike consolidating before a fresh rally?
For a stock that could do nothing wrong for a long time, it's been a tough couple of months for Nike Inc. (NYSE: NKE). A dodgy earnings report last month, including the dreaded weak forward
![Is Nike consolidating before a fresh rally?: https://www.marketbeat.com/logos/articles/med_20240126092539_is-nike-consolidating-before-a-fresh-rally.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3NZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a973e1215e5f04bd4e1b18308279c7b5184e9ecf/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126092539_is-nike-consolidating-before-a-fresh-rally.jpg?locale=de)
Is Nike consolidating before a fresh rally?
For a stock that could do nothing wrong for a long time, it's been a tough couple of months for Nike Inc. (NYSE: NKE). A dodgy earnings report last month, including the dreaded weak forward
![3 well-known consumer cyclical stocks offering 5% dividends: https://www.marketbeat.com/logos/articles/med_20240126063644_3-well-known-consumer-cyclical-stocks-offering-5-d.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMklZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d3edfa7911b9ed5f23f091fc1499f4534983e6f8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126063644_3-well-known-consumer-cyclical-stocks-offering-5-d.jpg?locale=de)
3 well-known consumer cyclical stocks offering 5% dividends
Lately, the major domestic stock indices are getting into a habit of setting fresh all-time highs.
Unwavering hopes of aggressive Federal Reserve interest rate cuts in 2024 have pushed the Dow
![3 well-known consumer cyclical stocks offering 5% dividends: https://www.marketbeat.com/logos/articles/med_20240126063644_3-well-known-consumer-cyclical-stocks-offering-5-d.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMklZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d3edfa7911b9ed5f23f091fc1499f4534983e6f8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126063644_3-well-known-consumer-cyclical-stocks-offering-5-d.jpg?locale=de)
3 well-known consumer cyclical stocks offering 5% dividends
Lately, the major domestic stock indices are getting into a habit of setting fresh all-time highs.
Unwavering hopes of aggressive Federal Reserve interest rate cuts in 2024 have pushed the Dow
![3 large caps near 52-week lows with large dividends: https://www.marketbeat.com/logos/articles/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDRZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3bd185cbcb79ac7eb575a93baf92e9e5017d38b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg?locale=de)
3 large caps near 52-week lows with large dividends
How fitting that Thursday night’s full moon was also referred to as the ‘wolf moon.’
U.S. stock indices howled to fresh all-time highs this week as the first full moon of 2024 lit up the evening
![Discover leads financial stocks higher, but is trouble lurking?: https://www.marketbeat.com/logos/articles/med_20240125194537_discover-leads-financial-stocks-higher-but-is-trou.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBellZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b1ef56b9302c85e619680c463b646b9e785d4aa9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125194537_discover-leads-financial-stocks-higher-but-is-trou.jpg?locale=de)
Discover leads financial stocks higher, but is trouble lurking?
Bank stocks and other financials tracked in the Financial Select Sector SPDR Fund (NYSEARCA: XLF) are rallying to two-year highs, with Discover Financial Services (NYSE: DFS) among the leaders.
![Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73381/AC-260124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd01ZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6a82654ad117bf9c39c27c505a5d8111b718295/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-260124.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 192% Biotech Aktientip nach 15.973%
26.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73381/AC-260124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd01ZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6a82654ad117bf9c39c27c505a5d8111b718295/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-260124.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 192% Biotech Aktientip nach 15.973%
26.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73381/AC-260124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd01ZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6a82654ad117bf9c39c27c505a5d8111b718295/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-260124.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 192% Biotech Aktientip nach 15.973%
26.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Abbott Laboratories on track for new highs in 2024: https://www.marketbeat.com/logos/articles/med_20240125084342_chart-abt-1252024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMThYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1bc09bf8706052cc87093d6ad0f0db9ca5de4fe0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125084342_chart-abt-1252024ver001.png?locale=de)
Abbott Laboratories on track for new highs in 2024
Abbott Laboratories (NYSE: ABT) share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with
![Super Micro Computer hits record high ahead of its earnings: https://www.marketbeat.com/logos/articles/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUVYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2d8a976d304914e6ad96f59f9f83d298cce5c665/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg?locale=de)
Super Micro Computer hits record high ahead of its earnings
Super Micro Computer (NASDAQ: SMCI), a major standout in the tech stock arena, experienced a remarkable 36% surge last Friday, reaching a new all-time high after the stock broke out of a
![Super Micro Computer hits record high ahead of its earnings: https://www.marketbeat.com/logos/articles/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUVYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2d8a976d304914e6ad96f59f9f83d298cce5c665/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg?locale=de)
Super Micro Computer hits record high ahead of its earnings
Super Micro Computer (NASDAQ: SMCI), a major standout in the tech stock arena, experienced a remarkable 36% surge last Friday, reaching a new all-time high after the stock broke out of a
![The EV bubble burst: Tesla looks to the future but wait to buy in: https://www.marketbeat.com/logos/articles/med_20240125072305_chart-tsla-1252024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDhYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--840c0b565f02f439ca9905328dc4d7e4f6e398b7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125072305_chart-tsla-1252024ver001.png?locale=de)
The EV bubble burst: Tesla looks to the future but wait to buy in
If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s (NASDAQ: TSLA) Q4 results and outlook for 2024 should do it. The
![The EV bubble burst: Tesla looks to the future but wait to buy in: https://www.marketbeat.com/logos/articles/med_20240125072305_chart-tsla-1252024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDhYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--840c0b565f02f439ca9905328dc4d7e4f6e398b7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125072305_chart-tsla-1252024ver001.png?locale=de)
The EV bubble burst: Tesla looks to the future but wait to buy in
If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s (NASDAQ: TSLA) Q4 results and outlook for 2024 should do it. The
![When does 3M’s stumble become a buy?: https://www.marketbeat.com/logos/articles/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUFYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dcfbd55352d682ee70c305a6527f5c9fc37160a1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg?locale=de)
When does 3M’s stumble become a buy?
Having put in what looked like a bottom last October, investors in 3M Co (NYSE: MMM) would have been looking ahead to 2024 with bullish optimism. Sure, the stock had sunk 60% since the summer of
![When does 3M’s stumble become a buy?: https://www.marketbeat.com/logos/articles/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUFYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dcfbd55352d682ee70c305a6527f5c9fc37160a1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg?locale=de)
When does 3M’s stumble become a buy?
Having put in what looked like a bottom last October, investors in 3M Co (NYSE: MMM) would have been looking ahead to 2024 with bullish optimism. Sure, the stock had sunk 60% since the summer of
![This one wireless service stock could blow past earnings: https://www.marketbeat.com/logos/articles/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--adb6e5732bfe96f42df4893e6fdc7d15de813a22/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg?locale=de)
This one wireless service stock could blow past earnings
Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive
![This one wireless service stock could blow past earnings: https://www.marketbeat.com/logos/articles/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--adb6e5732bfe96f42df4893e6fdc7d15de813a22/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg?locale=de)
This one wireless service stock could blow past earnings
Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive
![Flutter Entertainment flies to $100 ahead of NYSE listing: https://www.marketbeat.com/logos/articles/med_20240125070158_flutter-entertainment-flies-to-100-ahead-of-nyse-l.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL29XYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--370c70070ba75876d083126c3b0fe0db8e72c639/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125070158_flutter-entertainment-flies-to-100-ahead-of-nyse-l.jpg?locale=de)
Flutter Entertainment flies to $100 ahead of NYSE listing
Shares of Irish online sports betting (OSB) and gaming leader Flutter Entertainment plc (OTCMKTS:PDYPY) lept 23% to $100.23 last week in three-times normal volume. The surge came ahead of